BR9914863A - Derivados aromáticos e complexos de ferro dos mesmos para uso como agentes de normalização do nìvel de ferro - Google Patents
Derivados aromáticos e complexos de ferro dos mesmos para uso como agentes de normalização do nìvel de ferroInfo
- Publication number
- BR9914863A BR9914863A BR9914863-3A BR9914863A BR9914863A BR 9914863 A BR9914863 A BR 9914863A BR 9914863 A BR9914863 A BR 9914863A BR 9914863 A BR9914863 A BR 9914863A
- Authority
- BR
- Brazil
- Prior art keywords
- iron
- aromatic derivatives
- complexes
- normalizing agents
- level normalizing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
<B>"DERIVADOS AROMáTICOS E COMPLEXOS DE FERRO DOS MESMOS PARA USO COMO AGENTES DE NORMALIZAçãO DO NìVEL DE FERRO"<D>. A presente invenção se refere à derivados aromáticos de fórmula (I), em que R~ 1~ é (a), R~ 3~ e R~ 4~ são selecionados entre H e OH, desde que R~ 3~ e R~ 4~ não sejam simultaneamente H, e R~ 2~ é H; ou R~ 1~ e R~ 2~ tomados juntos, representam (b), onde R~ 5~ é selecionado dentre CH~ 3~ e (CH~ 2~) ~ 5~OH, para os complexos de ferro do mesmo e ao seu uso para preparação de composições farmacêuticas para a normalização do nível de ferro.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002350A IT1303688B1 (it) | 1998-11-02 | 1998-11-02 | Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo. |
| PCT/EP1999/008222 WO2000026205A1 (en) | 1998-11-02 | 1999-10-29 | Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9914863A true BR9914863A (pt) | 2001-07-03 |
Family
ID=11380986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9914863-3A BR9914863A (pt) | 1998-11-02 | 1999-10-29 | Derivados aromáticos e complexos de ferro dos mesmos para uso como agentes de normalização do nìvel de ferro |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6455578B1 (pt) |
| EP (1) | EP1124814B1 (pt) |
| JP (1) | JP2002528539A (pt) |
| AR (1) | AR021037A1 (pt) |
| AT (1) | ATE229947T1 (pt) |
| AU (1) | AU756726B2 (pt) |
| BR (1) | BR9914863A (pt) |
| CA (1) | CA2348380C (pt) |
| CZ (1) | CZ299542B6 (pt) |
| DE (1) | DE69904635T2 (pt) |
| DK (1) | DK1124814T3 (pt) |
| ES (1) | ES2189537T3 (pt) |
| IL (2) | IL142813A0 (pt) |
| IT (1) | IT1303688B1 (pt) |
| PL (1) | PL198826B1 (pt) |
| SK (1) | SK286308B6 (pt) |
| WO (1) | WO2000026205A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009531379A (ja) * | 2006-03-29 | 2009-09-03 | ビーエーエスエフ ソシエタス・ヨーロピア | 鉄代謝機能障害を治療するためのストロビルリンの使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4122200A (en) * | 1974-11-20 | 1978-10-24 | Lipha, Lyonnaise Industrielle Pharmaceutique | 6',2-(2'Arylchromonyl) propionic acids, and analgesic and anti-inflammatory derivatives thereof |
| ATE14579T1 (de) * | 1979-03-20 | 1985-08-15 | Fisons Plc | Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen. |
| EP0346279A1 (de) * | 1988-06-06 | 1989-12-13 | Ciba-Geigy Ag | Propan-1,3-dionderivate und deren Verwendung als Stabilisatoren für chlorhaltige Polymerisate |
-
1998
- 1998-11-02 IT IT1998MI002350A patent/IT1303688B1/it active
-
1999
- 1999-10-29 CZ CZ20011461A patent/CZ299542B6/cs not_active IP Right Cessation
- 1999-10-29 JP JP2000579593A patent/JP2002528539A/ja active Pending
- 1999-10-29 CA CA002348380A patent/CA2348380C/en not_active Expired - Fee Related
- 1999-10-29 AT AT99971418T patent/ATE229947T1/de not_active IP Right Cessation
- 1999-10-29 EP EP99971418A patent/EP1124814B1/en not_active Expired - Lifetime
- 1999-10-29 AR ARP990105492A patent/AR021037A1/es unknown
- 1999-10-29 IL IL14281399A patent/IL142813A0/xx active IP Right Grant
- 1999-10-29 US US09/830,800 patent/US6455578B1/en not_active Expired - Fee Related
- 1999-10-29 SK SK556-2001A patent/SK286308B6/sk not_active IP Right Cessation
- 1999-10-29 DE DE69904635T patent/DE69904635T2/de not_active Expired - Lifetime
- 1999-10-29 WO PCT/EP1999/008222 patent/WO2000026205A1/en active IP Right Grant
- 1999-10-29 AU AU11573/00A patent/AU756726B2/en not_active Ceased
- 1999-10-29 BR BR9914863-3A patent/BR9914863A/pt not_active Application Discontinuation
- 1999-10-29 PL PL347940A patent/PL198826B1/pl not_active IP Right Cessation
- 1999-10-29 DK DK99971418T patent/DK1124814T3/da active
- 1999-10-29 ES ES99971418T patent/ES2189537T3/es not_active Expired - Lifetime
-
2001
- 2001-04-25 IL IL142813A patent/IL142813A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU756726B2 (en) | 2003-01-23 |
| US6455578B1 (en) | 2002-09-24 |
| DE69904635T2 (de) | 2003-10-02 |
| IL142813A0 (en) | 2002-03-10 |
| ITMI982350A1 (it) | 2000-05-02 |
| JP2002528539A (ja) | 2002-09-03 |
| AR021037A1 (es) | 2002-06-12 |
| CZ20011461A3 (cs) | 2001-08-15 |
| ATE229947T1 (de) | 2003-01-15 |
| DK1124814T3 (da) | 2003-04-14 |
| DE69904635D1 (de) | 2003-01-30 |
| SK286308B6 (en) | 2008-07-07 |
| CA2348380C (en) | 2009-02-17 |
| IT1303688B1 (it) | 2001-02-23 |
| PL347940A1 (en) | 2002-04-22 |
| IL142813A (en) | 2006-12-10 |
| PL198826B1 (pl) | 2008-07-31 |
| ES2189537T3 (es) | 2003-07-01 |
| WO2000026205A1 (en) | 2000-05-11 |
| SK5562001A3 (en) | 2001-09-11 |
| EP1124814B1 (en) | 2002-12-18 |
| AU1157300A (en) | 2000-05-22 |
| EP1124814A1 (en) | 2001-08-22 |
| CA2348380A1 (en) | 2000-05-11 |
| CZ299542B6 (cs) | 2008-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0007500A (pt) | Composto triazol, fármaco, e, uso do composto | |
| BR0014060A (pt) | Derivado de quinolil propil piperidina, processo para preparação do mesmo, e, composição farmacêutica | |
| CY1116145T1 (el) | S-φθορομεθυλεστερας 6.αλφα.,9.αλφα-διφθορο-17.αλφα.-'(2-φουρανυλκαρβοξυλ) οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4-διεν-17-καρβοθειοτικου οξεος ως αντιφλεγμονωδης παραγοντας | |
| TR200103186T2 (tr) | MEK enzimlerinin inhibitörleri olarak kinolin türevleri | |
| BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR0111667A (pt) | Novos compostos | |
| BR0112030A (pt) | Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| TR199902606T2 (xx) | Farnesil transferaz� engelleyici kinazolinonlar. | |
| TR200101961T2 (tr) | 1,2-halkalı kinolin türevleri | |
| TR199800720T2 (xx) | Farnesil transferaz inhibe eden 2-kinolon t�revleri. | |
| BR9810984A (pt) | Composto de triazol, uso do mesmo, e, composição farmacêutica | |
| MA27427A1 (fr) | Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie | |
| DE69332563D1 (de) | 1-(2-oxo-acetyl)-piperidin-2-carbonsäure derivate als sensibilisatoren für multi-drug-resistente krebszellen | |
| TNSN99006A1 (fr) | 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| BR9806752A (pt) | Ftalazinonas. | |
| HUP0102521A2 (hu) | Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer | |
| BR9713147A (pt) | Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal. | |
| BR9813390A (pt) | Composto, processo para a preparação do mesmo, e uso do mesmo, composição farmacêutica, processo para a preparação da mesma, e, processo para efetuar a imunossupressão | |
| UY24555A1 (es) | Nuevos compuestos | |
| MA29213B1 (fr) | Quinolones a substitution macrolones - amino | |
| BR0009703A (pt) | Compostos ou sais, ou composições uso dos mesmos, e, formulações farmacêuticas | |
| BR9913592A (pt) | Compostos, processo de preparação dos compostos, e, composições farmacêuticas | |
| BR0210028A (pt) | Agentes antibacterianos | |
| NO913923L (no) | 17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |